Philadelphia
GlaxoSmithKline will build a 205,000-sf facility in the Philadelphia Navy Yard. The four-story building will be developed by Liberty Property Trust and Synterra Partners and is expected to achieve LEED Platinum sustainable design certification. Robert A.M. Stern Architects (RAMSA) is providing design services for the $81 million project. Site work will begin in March of 2011 with construction commencing in summer of 2011. Completion is expected by early 2013.
